Valuation : Ono Pharmaceutical Co., Ltd.

Market Cap 1,155B 7.22B 6.22B 5.83B 5.32B 10.03B 690B 10.06B 69.18B 26.99B 348B 27.1B 26.51B P/E 2027 *
15.8x
P/E 2028 * 18.3x
Enterprise Value 953B 5.96B 5.14B 4.82B 4.4B 8.28B 570B 8.31B 57.13B 22.29B 288B 22.38B 21.89B EV / Sales 2027 *
2.08x
EV / Sales 2028 * 2.02x
Free-Float
81.92%
Yield 2027 *
3.18%
Yield 2028 * 3.15%
07-31 Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 MT
07-30 Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-28 Ono Pharmaceutical Co., Ltd. Partners with Phylo, Inc. to Embed Agentic AI with Every Discovery Scientist CI
06-19 Mizuho Securities Upgrades Ono Pharmaceutical to Buy from Neutral; Price Target is 3,200 Yen MT
06-18 Ono Pharmaceutical to Dispose of 47 Million Yen Treasury Shares Under Stock Compensation Plan MT
06-01 Ono Pharmaceutical Co., Ltd. Announces Oral Presentation Of New Data From The Phase 2 Clinical Study Of ONO-4578 In Certain Gastric Cancers At The ASCO 2026 Annual Meeting CI
05-29 Jefferies Adjusts Ono Pharmaceutical's Price Target to 2,500 Yen From 1,750 Yen, Keeps at Hold MT
05-08 Ono Pharmaceutical's Attributable Profit Jumps 39% in Fiscal Year 2025 MT
05-07 Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 CI
05-07 Ono Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027 CI
05-07 Ono Pharmaceutical Co., Ltd. Proposes Year End Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 19, 2026 and Provides Dividend Forecasts for the Second Quarter of Year Ending March 31, 2027 and Fiscal Year Ending March 31, 2027 CI
04-22 Top Midday Stories: GE Vernova Shares Gain on Strong Q1 Earnings, Guidance; Vertiv Lifts Guidance After Q1 EPS, Revenue Beats, Shares Fall MT
04-22 Merck, Rivals Show Interest in Inhibrx's Experimental Cancer Drug MT
1 day-0.26%
1 week+0.27%
Current month+2.79%
1 month+2.79%
3 months+5.53%
6 months-1.51%
Current year+12.80%
1 week 2,420
Extreme 2420
2,517.5
1 month 2,264.5
Extreme 2264.5
2,517.5
Current year 2,114.5
Extreme 2114.5
2,674.5
1 year 1,670.5
Extreme 1670.5
2,674.5
3 years 1,474
Extreme 1474
2,966.5
5 years 1,474
Extreme 1474
3,990
10 years 1,474
Extreme 1474
3,990
Manager TitleAgeSince
Chief Executive Officer 67 2024-03-31
Director of Finance/CFO - 2026-03-31
President 57 2024-03-31
Director TitleAgeSince
Chairman 67 2024-03-31
Director/Board Member 57 2020-05-31
Director/Board Member 77 2018-06-25
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%+0.27%+43.89%-11.26% 7.22B
+3.38%+3.92%+26.96%+78.55% 48.2B
+0.66%+0.33%+54.40%+120.88% 39.97B
-2.49%+5.21%+17.18%+85.56% 12.43B
-1.00%-2.00%-11.21%+12.05% 12.03B
+0.19%0.00%+29.35%+150.00% 9.35B
-1.87%-1.28%+25.69%+49.12% 7.75B
-1.39%+3.74%+28.71%+223.40% 7.43B
-0.53%-1.53%-36.09%+17.02% 5.3B
+1.26%+0.61%+46.90%+108.52% 4.65B
Average -0.17%+1.86%+22.58%+83.38% 15.43B
Weighted average by Cap. +0.82%+1.31%+29.70%+89.30%

Financials

2027 *2028 *
Net sales 458B 2.87B 2.47B 2.32B 2.11B 3.98B 274B 3.99B 27.47B 10.72B 138B 10.76B 10.53B 448B 2.8B 2.42B 2.26B 2.07B 3.89B 268B 3.91B 26.87B 10.48B 135B 10.52B 10.3B
Net income 72.89B 456M 393M 368M 336M 633M 43.55B 635M 4.37B 1.7B 21.98B 1.71B 1.67B 63.15B 395M 340M 319M 291M 548M 37.73B 550M 3.78B 1.48B 19.05B 1.48B 1.45B
Net Debt -201B -1.26B -1.08B -1.02B -927M -1.75B -120B -1.75B -12.05B -4.7B -60.65B -4.72B -4.62B -250B -1.56B -1.35B -1.26B -1.15B -2.17B -149B -2.18B -14.96B -5.84B -75.3B -5.86B -5.73B
Logo Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.
Employees
4,206
Date Price Change Volume
26-08-31 JP¥2,450.50 -0.26% 1,569,500
26-08-28 JP¥2,457.00 +0.04% 1,269,300
26-08-27 JP¥2,456.00 -1.41% 1,045,700
26-08-26 JP¥2,491.00 +1.30% 1,811,900
26-08-25 JP¥2,459.00 +0.61% 1,772,500
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,457.00JPY
Average target price
2,508.33JPY
Spread / Average Target
+2.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4528 Stock